Drs. Shannon Holden and David Bragin-Sanchez share new developments in heart failure pharmacotherapy and guidelines, while stressing the importance of the role of the clinical pharmacist as part of a collaborative team.

Guest speakers:

David Bragin-Sanchez, MD, FACC, FESC, FISC

Moderator:

Show Notes:

[02:27-04:07] The increased focus on cardiology lately

[04:08-06:47] Recent updates to the guidelines

[06:48-09:05] What clinicians need to know about guidelines moving forward

[09:06-10:47] How guideline changes impact patients and workflow

[10:48-13:42] Other ways pharmacy staff can contribute and what is their role in your clinic

[13:43-16:37] Additional thoughts on role of a pharmacist in this type of clinic

[16:38-19:31] Initiating SGLT2 inhibitors prior to discharge in some heart failure patients

[19:32-23:07] Future roles for pharmacists in this kind of setting

[23:08-25:09] Advice for pharmacists getting involved with this type of clinic setting and these types of patients

Links | Resources:

Vizient Pharmacy Market Outlook Member link: Click Here

Vizient Pharmacy Market Outlook highlights public version: Click Here

AHA/ACC/HFSA 2022 Guidelines

CHARM trial

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed